2015 – 2030 GLOBAL HYDROXYCHLOROQUINE & CHLOROQUINE MARKET FORECAST & OPPORTUNITIES
www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING
Scope of Report Product of Interest (POI): Hydroxychloroquine & Chloroquine
Global Hydroxychloroquine & Chloroquine market is expected to grow at a formidable rate during the forecast period. Chloroquine is commonly available in the market under the generic brand name Aralen. The global Hydroxychloroquine & Chloroquine market is driven by the increasing use of the drug for treating various diseases. Recently, it has been identified though not approved by the FDA that the drug can be helpful in the treatment of novel coronavirus disease. Based on type, market can be segregated into injectables and tablets.
Market Segmentation TYPE •
Injectables
•
Tablets
STRENGTH •
250mg
•
500mg
ROUTE OF ADMINISTRATION
END-USE •
Rheumatoid Arthritis
•
Malaria
•
COVID-19
•
Others
REGION •
Asia-Pacific
•
North America
•
Europe
•
Oral
•
South America
•
Intravenous
•
Middle East & Africa
Year Range Review Period
2015 – 2018 Base Year
2019 Estimated Year
2020 Forecast Period
2021 – 2030
2
Table of Contents S. No.
Contents
1.
Product Overview
2.
Research Methodology
3.
Analyst View
4.
Voice of Customer
5.
4.1.
Brand Awareness (Aided/Unaided)
4.2.
Product Awareness
4.3.
Customer Satisfaction Analysis
4.4.
Unmet Needs/Challenges
Global Hydroxychloroquine & Chloroquine Market Outlook 5.1.
Market Size & Forecast 5.1.1.
5.2.
5.3.
By Value
Market Share & Forecast 5.2.1.
By Type (Injectables, Tablets)
5.2.2.
By Route of Administration (Oral, Intravenous)
5.2.3.
By Strength (250mg, 500mg)
5.2.4.
By Application (Rheumatoid Arthritis, Malaria, COVID-19, Others)
5.2.5.
By Company (2019)
5.2.6.
By Region (Asia-Pacific, North America, Europe, South America, Middle East & Africa)
Market Attractiveness Index
3
Table of Contents S. No. 6.
Contents Asia-Pacific Hydroxychloroquine & Chloroquine Market Outlook 6.1.
Market Size & Forecast 6.1.1.
6.2.
By Value
Market Share & Forecast 6.2.1.
By Type
6.2.2
By Application
6.2.3.
By Country (China, India, Australia, Japan, South Korea) 6.2.3.1.
China Hydroxychloroquine & Chloroquine Market Outlook 6.2.3.1.1.
Market Size & Forecast 6.2.3.1.1.1.
6.2.3.1.2.
6.2.3.2.
By Value
Market Share & Forecast 6.2.3.1.2.1.
By Type
6.2.3.1.2.2.
By Application
India Hydroxychloroquine & Chloroquine Market Outlook 6.2.3.2.1.
Market Size & Forecast 6.2.3.2.1.1.
6.2.3.2.2.
By Value
Market Share & Forecast 6.2.3.2.2.1.
By Type
6.2.3.2.2.2.
By Application
4
Table of Contents S. No.
Contents 6.2.3.3.
Australia Hydroxychloroquine & Chloroquine Market Outlook 6.2.3.3.1.
Market Size & Forecast 6.2.3.3.1.1.
6.2.3.3.2.
6.2.3.4.
Market Share & Forecast
6.2.3.3.2.1.
By Type
6.2.3.3.2.2.
By Application
Japan Hydroxychloroquine & Chloroquine Market Outlook 6.2.3.4.1.
Market Size & Forecast 6.2.3.4.1.1.
6.2.3.4.2.
6.2.3.5.
By Value
By Value
Market Share & Forecast 6.2.3.4.2.1.
By Type
6.2.3.4.2.2.
By Application
South Korea Hydroxychloroquine & Chloroquine Market Outlook 6.2.3.5.1.
Market Size & Forecast 6.2.3.5.1.1.
6.2.3.5.2.
By Value
Market Share & Forecast 6.2.3.5.2.1.
By Type
6.2.3.5.2.2.
By Application
5
Table of Contents S. No. 7.
Contents North America Hydroxychloroquine & Chloroquine Market Outlook 7.1.
Market Size & Forecast 7.1.1.
7.2.
By Value
Market Share & Forecast 7.2.1.
By Type
7.2.2.
By Application
7.2.3.
By Country (United States, Mexico, Canada) 7.2.3.1.
United States Hydroxychloroquine & Chloroquine Market Outlook 7.2.3.1.1.
Market Size & Forecast 7.2.3.1.1.1.
7.2.3.1.2.
7.2.3.2.
By Value
Market Share & Forecast 7.2.3.1.2.1.
By Type
7.2.3.1.2.2.
By Application
Mexico Hydroxychloroquine & Chloroquine Market Outlook 7.2.3.2.1.
Market Size & Forecast 7.2.3.2.1.1.
7.2.3.2.2.
By Value
Market Share & Forecast 7.2.3.2.2.1.
By Type
7.2.3.2.2.2.
By Application
6
Table of Contents S. No.
Contents 7.2.3.3.
Canada Hydroxychloroquine & Chloroquine Market Outlook 7.2.3.3.1.
Market Size & Forecast 7.2.3.3.1.1.
7.2.3.3.2.
8.
By Value
Market Share & Forecast 7.2.3.3.2.1.
By Type
7.2.3.3.2.2.
By Application
Europe Hydroxychloroquine & Chloroquine Market Outlook 8.1.
Market Size & Forecast 8.1.1.
8.2.
By Value
Market Share & Forecast 8.2.1.
By Type
8.2.2
By Application
8.2.3.
By Country (France, Germany, United Kingdom, Italy, Spain) 8.2.3.1.
France Hydroxychloroquine & Chloroquine Market Outlook
8.2.3.1.1.
Market Size & Forecast 8.2.3.1.1.1.
8.2.3.1.2.
By Value
Market Share & Forecast 8.2.3.1.2.1.
By Type
8.2.3.1.2.2.
By Application
7
Table of Contents S. No.
Contents 8.2.3.2.
Germany Hydroxychloroquine & Chloroquine Market Outlook 8.2.3.2.1.
Market Size & Forecast 8.2.3.2.1.1.
8.2.3.2.2.
8.2.3.3.
Market Share & Forecast 8.2.3.2.2.1.
By Type
8.2.3.2.2.2.
By Application
United Kingdom Hydroxychloroquine & Chloroquine Market Outlook 8.2.3.3.1.
Market Size & Forecast 8.2.3.3.1.1.
8.2.3.3.2.
8.2.3.4.
By Value
By Value
Market Share & Forecast 8.2.3.3.2.1.
By Type
8.2.3.3.2.2.
By Application
Italy Hydroxychloroquine & Chloroquine Market Outlook 8.2.3.4.1.
Market Size & Forecast 8.2.3.4.1.1.
8.2.3.4.2.
By Value
Market Share & Forecast 8.2.3.4.2.1.
By Type
8.2.3.4.2.2.
By Application
8
Table of Contents S. No.
Contents 8.2.3.5.
Spain Hydroxychloroquine & Chloroquine Market Outlook 8.2.3.5.1.
Market Size & Forecast 8.2.3.5.1.1.
8.2.3.5.2.
9.
By Value
Market Share & Forecast 8.2.3.5.2.1.
By Type
8.2.3.5.2.2.
By Application
South America Hydroxychloroquine & Chloroquine Market Outlook 9.1.
Market Size & Forecast 9.1.1.
9.2.
By Value
Market Share & Forecast 9.2.1.
By Type
9.2.2.
By Application
9.2.3.
By Country (Brazil, Argentina, Colombia) 9.2.3.1.
Brazil Hydroxychloroquine & Chloroquine Market Outlook 9.2.3.1.1.
Market Size & Forecast 9.2.3.1.1.1.
9.2.3.1.2.
By Value
Market Share & Forecast
9.2.3.1.2.1.
By Type
9.2.3.1.2.2.
By Application
9
Table of Contents S. No.
Contents 9.2.3.2.
Argentina Hydroxychloroquine & Chloroquine Market Outlook 9.2.3.2.1.
Market Size & Forecast
9.2.3.2.1.1. 9.2.3.2.2.
9.2.3.3.
Market Share & Forecast 9.2.3.2.2.1.
By Type
9.2.3.2.2.2.
By Application
Colombia Hydroxychloroquine & Chloroquine Market Outlook 9.2.3.3.1
Market Size & Forecast 9.2.3.3.1.1.
9.2.3.3.2.
10.
By Value
By Value
Market Share & Forecast 9.2.3.3.2.1.
By Type
9.2.3.3.2.2.
By Application
Middle East & Africa Hydroxychloroquine & Chloroquine Market Outlook
10.1.
Market Size & Forecast 10.1.1.
10.2.
By Value
Market Share & Forecast 10.2.1.
By Type
10.2.2
By Application
10.2.3.
By Country (South Africa, Saudi Arabia, UAE)
10
Table of Contents S. No.
Contents 10.2.3.1.
South Africa Hydroxychloroquine & Chloroquine Market Outlook 10.2.3.1.1.
Market Size & Forecast 10.2.3.1.1.1.
10.2.3.1.2.
10.2.3.2.
Market Share & Forecast 10.2.3.1.2.1.
By Type
10.2.3.1.2.2.
By Application
Saudi Arabia Hydroxychloroquine & Chloroquine Market Outlook 10.2.3.2.1.
Market Size & Forecast 10.2.3.2.1.1.
10.2.3.2.2.
10.2.3.3.
By Value
By Value
Market Share & Forecast 10.2.3.2.2.1.
By Type
10.2.3.2.2.2.
By Application
UAE Hydroxychloroquine & Chloroquine Market Outlook 10.2.3.3.1.
Market Size & Forecast 10.2.3.3.1.1.
10.2.3.3.2.
By Value
Market Share & Forecast 10.2.3.3.2.1.
By Type
10.2.3.3.2.2.
By Application
11
Table of Contents S. No.
Contents 10.2.3.4.
Kuwait Hydroxychloroquine & Chloroquine Market Outlook
10.2.3.4.1.
Market Size & Forecast 10.2.3.4.1.1.
10.2.3.4.2.
11.
By Value
Market Share & Forecast 10.2.3.4.2.1.
By Type
10.2.3.4.2.2.
By Application
Market Dynamics 11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
13.
Pricing Analysis
14.
Competitive Landscape (Leading Company Profiles)
15.
Policy and Regulatory Landscape
16.
Strategic Recommendations
17.
About Us & Disclaimer
12
RESEARCH METHODOLOGY
Research Methodology
Market Profiling
In-depth secondary research was conducted to determine top players in the global Hydroxychloroquine & Chloroquine market, overall market size and segmental market size.
Formulating Questionnaire
In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.
Developing list of respondents
Data Collection
Data Validation
Data obtained as a result of primary and secondary research was validated through rigorous triangulation.
TechSci conducted interviews with industry experts and industry players for data collection and verification.
List of industry players and industry specialists was developed.
Primary Research
Data Collection
Data Filter & Analysis
Research & Intelligence
Actionable Insights
Business Solution
LinkedIn TechSci Internal Database
✓ Recent Developments ✓ Market Changing Aspects/Dynamics ✓ Government Policies ✓ Final Conclusion
✓ Identifying Key Opinion Leaders ✓ Questionnaire Design ✓ In-depth Interviews
Primary Research ✓ ✓
Desk Research
Secondary Research ✓ ✓ ✓ ✓ ✓ ✓ ✓
Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc.
Data Analysis
The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global Hydroxychloroquine & Chloroquine market.
Company Analysis ✓ Market Participants ✓ Key Strengths
Paid Sources
✓ ✓
Factiva Hoovers
14
Research Methodology Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global Hydroxychloroquine & Chloroquine market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increasing use of the drug for treating various diseases. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global Hydroxychloroquine & Chloroquine market.
Methodology Followed for Calculation of Market Size:
•
Market Size By Value: Market size, in terms of Value, for the year 2019 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as Hydroxychloroquine & Chloroquine manufacturer & supplier companies, channel partners, market influencers & end users, industry experts, and other industry participants.
•
The team interviewed more than 15 – 20 Hydroxychloroquine & Chloroquine manufacturer & supplier companies, 45 – 50 channel partners, 80 – 100 end users, and 15 – 20 Industry experts and other value chain stakeholders in the global Hydroxychloroquine & Chloroquine market to obtain the overall market size for 2015-2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2014-2019.
15
Research Methodology •
Respondents were asked about the current and future market growth rates, market shares by type, by route of administration, by strength, by application, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and supplier wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares: •
Market shares by type, by route of administration, by strength, by application, by company and by region were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various technologies of Hydroxychloroquine & Chloroquine. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting: •
TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
•
Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global Hydroxychloroquine & Chloroquine market, TechSci Research used various forecast techniques such as: ✓
Moving Average
✓
Time Series Analysis
✓
Regression Analysis
✓
Econometric and Judgmental Analysis
16
Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data.
Partial List of Companies Interviewed
Key Secondary Sources
▪ ARTECEF B.V.
▪ World Bank
▪ Fishman Chemical, LLC
▪ TechSci Research Proprietary Database & Knowledge
▪ Uniprix Inc. ▪ Bayer AG ▪ Abcam Inc.
Repository ▪ Company Annual Reports ▪ Industry Magazines
▪ Recipharm
▪ Industry Reports ▪ Teva Pharmaceuticals
▪ Mylan NV ▪ Abbott
▪ News Dailies ▪ Credible Paid Databases
▪ Novartis AG 17
INDUSTRY BRIEF According to TechSci Research report, “Global Hydroxychloroquine and Chloroquine Market By Type, By Route of Administration, By Strength, By Application, By Region, Competition, Forecast & Opportunities, 2030”, the global hydroxychloroquine and chloroquine market is projected to reach $ 285 million in 2020, predominantly on account of rising use of the drug in treating novel coronavirus COVID-19. Though, it has not been proven clinically that the drug can be used in treating coronavirus, but it has been identified that the drug is helpful in improving the early symptoms of the disease, especially the respiratory problems. Globally, Ipca and Cadila are among the top manufacturers of these drugs.
The global hydroxychloroquine and chloroquine market are segmented based on type, route of administration, strength, application and region. Based on type, the market can be categorized into injectables and tablets. The tablets segment is expected to dominate the market during the forecast period since these are cost effective. Based on route of administration, the market can be bifurcated into oral and intravenous. The oral segment is expected to dominate the market since the drug is generally consumed orally in the form of tablets. Based on application, the market can be categorized into rheumatoid arthritis, malaria, COVID-19 and others. The COVID-19 segment is expected to register the highest growth during forecast period since it has been identified that the drug can be used to treat the disease, though not clinically proven. Additionally, studies suggest that it is helpful in treating some symptoms of the disease and is being used widely in the treatment guidelines of COVID-19. Countries such as China, South Korea and Belgium have added hydroxychloroquine and chloroquine in their coronavirus disease treatment guidelines. Also, studies suggest that the drug has been helpful in treating few cases of the disease in France. Due to rising spread of the pandemic, FDA issued an Emergency Use Authorization for the treatment of novel coronavirus disease (COVID-19). Ipca Laboratories Ltd, Zydus Cadila, Novartis AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Rising Pharma Holdings Inc, Abcam plc, Mylan N.V, and Abbott are some of the leading players operating in global chloroquine market. “North America is expected to register significant growth in the hydroxychloroquine and chloroquine market during the forecast period, owing to the use of drug for treating COVID-19. Additionally, the drug is being used in the coronavirus treatment guidelines in various other countries. If it gets proven clinically that the drug can be used for the treatment of COVID-19, then this is expected to create lucrative opportunities for the market players in foreseeable future.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
18
SAMPLE DATA - SNAPSHOT Global Hydroxychloroquine & Chloroquine Market Size, By Value (USD Million), 2015-2030F
5.00
6.00
8.00
7.00
2015
9.00
10.00
2019
2020E
11.00
12.00
13.00
By Value (USD Million)
CAGR By Value
14.00
15.00
16.00
17.00
18.00
2024F
19.00
20
2030F
CAGR By Value
YY%
XX%
Europe Hydroxychloroquine & Chloroquine Market Share, By Application, By Value, 2015–2030F Rheumatoid Arthritis Malaria COVID-19 Others 2029F 2027F 2025F 2023F 2021F 2019 2017 2015
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
Germany Hydroxychloroquine & Chloroquine Market Share, By Type, By Value, 2015-2030F Injectables 2029F 2027F
2025F 2023F 2021F 2019
2017 2015
50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50%
Tables 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50%
19
REPORT ORDERING
Report Name: GLOBAL HYDROXYCHLOROQUINE & CHLOROQUINE MARKET FORECAST & OPPORTUNITIES 2015 – 2030
Report Price License Type
Price
Electronic Access - Single User License
$4450
Electronic Access - Multi-User License
$5450
Custom Research License
$9450
To View Sample OR Purchase Report
20
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting
models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports •
Global Chloroquine Market By Type (Injectables, Capsules, Tablets), By Route of Administration (Oral v/s Intravenous), By Dosage (5mg, 500mg, 1000mg), By Application (Arthrophlogosis, Malaria, COVID-19, Others), By Region, Forecast & Opportunities, 2030
•
Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET), By Application (Cardiology, Respiratory, Orthopaedics, Others), By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Others), By Route of Administration (Oral, Intravenous, Nasal), By End-User (Hospitals, Diagnostic centers, Others), By Region, Forecast & Opportunities, 2030
TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Europe
54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com
Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.